Incrementalists need not apply.
Fe3 is developing a novel approach for the treatment of iron-deficiency anemia.
A neurovascular company focused on treating hemorrhagic stroke with a new technology for rapidly treating aneurysms and fistulas in the brain.
An early-stage venture creating innovative implantable devices for the management of chronic pain.
Delivering peptides, proteins and antibodies orally.
Developed an innovative product platform utilizing gastric stimulation for the treatment of obesity.
Returned To Investors
Ventures In Portfolio
Nurturing and growing companies with the potential to dramatically improve patient outcomes
Tell us how your massive breakthrough is going to transform healthcare